Future of the Large Volume Parenteral (LVP) Market: Trends, Innovations, and Key Forecasts Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Large Volume Parenteral (LVP) Market Size Growth Forecast: What to Expect by 2025?
In recent times, the large volume parenteral (LVP) market has experienced significant growth. The market, which is predicted to grow from $12.52 billion in 2024 to $13.57 billion in 2025, boasts a compound annual growth rate (CAGR) of 8.3%. This growth in the previous period can be linked to several factors including the rise in chronic illness incidences, an aging population, increased demand for sterile drugs, the growth of healthcare infrastructure, and the development of regulatory policies in the pharmaceutical sector.

How Will the Large Volume Parenteral (LVP) Market Size Evolve and Grow by 2029?
In the coming years, substantial expansion is projected for the large volume parenteral (LVP) market, with the size expected to surge to $19.46 billion by 2029, at a compound annual growth rate (CAGR) of 9.4%. Factors contributing to this growth in the projected timeframe include an increase in biologics and biosimilars demand, a rise in healthcare spending, the extension of pharma outsourcing, a heightened focus on bespoke medicine, and the worldwide expansion of pharmaceutical supply chains. Foreseen trends for the forecast period encompass enhancements in manufacturing technologies, incorporation of sophisticated innovations in pharmaceutical production, the utilization of single-use technologies, the creation of high-concentration formulas, and the proliferation of 3D printing applications within the pharmaceutical sector.

View the full report here:
https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

What Drivers Are Propelling the Growth of Large Volume Parenteral (LVP) Market Forward?
The escalating incidence of long-term diseases is anticipated to spur the expansion of the large-volume parenteral market. Chronic illnesses, which usually endure for three months or more and can progressively deteriorate, are primarily fuelled by tobacco use, exposure to smoke, and inadequate nutrition. Patients with such conditions necessitate an appropriate balance of essential nutrients to sustain strength. Parenteral delivery is a boon as it ensures the correct pharmaceutical dosage is administered directly into circulation, bypassing the digestive system. For example, as per the World Health Organization, a specialized UN agency based in Switzerland, in September 2023, there were 41 million fatalities globally, constituting 74% of deaths caused by non-communicable diseases (NCDs) or chronic illnesses annually. Hence, the escalating incidence of long-term ailments propels the expansion of the large-volume parenteral market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp

Which Emerging Trends Are Transforming the Large Volume Parenteral (LVP) Market in 2025?
The increasing prominence of product innovation is a primary trend observed in the large-volume parenteral market. To consolidate their market stance, top market participants are focusing on the development of novel products. An instance of this trend was seen in March 2022, when SGD Pharma SA, a firm based in France that manufactures molded and tubular glass for pharmaceutical primary packaging, introduced sterile 100-ml type I molded glass vials. These are ready for aseptic filling and finishing of parenteral medicinal formulations. Their design not only mitigates the risk of vial scratches, but it also facilitates visual inspection post filling and minimizes chances of rejection during quality control.

What Are the Key Segments in the Large Volume Parenteral (LVP) Market?
The large volume parenteral (LVP) market covered in this report is segmented -

1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP
2) By Volume: 100 ML - 250 ML, 250 ML - 500 ML, 500 ML - 1000 ML, 1000 ML -2000 ML, 2000 And More
3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion
4) By End-User: Hospital, Medical Centers, Other End Users

Subsegments:
1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags
2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags
3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12195&type=smp

Who Are the Key Players Shaping the Large Volume Parenteral (LVP) Market's Competitive Landscape?
Major companies operating in the large volume parenteral (LVP) market include Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Becton Dickinson and Company, Otsuka Holdings Co Ltd., Baxter International Inc., B Braun Melsungen AG, Grifols SA, Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Nelson Laboratories LLC, Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd, Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd, Pentagon Labs Ltd., DJ Labs Pvt Ltd., Higgs Healthcare.

What Geographic Markets Are Powering Growth in the Large Volume Parenteral (LVP) Market?
North America was the largest region in the large volume parenteral (LVP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (LVP) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12195

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.